Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dimethyl Fumarate for Intracerebral Hemorrhage
NCT04890379Phase 2Withdrawn
- Sponsor
- Xuanwu Hospital
- Start
- Jun 2021
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dimethyl fumarate in intracerebral hemorrhage (ICH), sponsored by Xuanwu Hospital. Planned start Jun 2021; status: withdrawn.
02
Drugs
dimethyl fumarate
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on NCT04890379.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04890379.